We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
-3.64%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$300B
AUM Growth
-$49.2B
Cap. Flow
-$29.5B
Cap. Flow %
-9.85%
Top 10 Hldgs %
13.34%
Holding
11,668
New
1,182
Increased
3,623
Reduced
5,175
Closed
1,160

Sector Composition

Rank Sector Weight
1 Technology 13.08%
2 Financials 7.19%
3 Healthcare 6.35%
4 Consumer Discretionary 5.55%
5 Industrials 4.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORGNW
9826
DELISTED
Origin Materials Inc Warrants
ORGNW
$1K ﹤0.01%
823
-6,478
-89% -$8.07K
OXBRW icon
9827
Oxbridge Re Holdings Ltd Warrant
OXBRW
$1K ﹤0.01%
+1,236
New +$713
PETWW
9828
DELISTED
Wag! Group Co Warrant
PETWW
$1K ﹤0.01%
+2,399
New +$765
PRLD icon
9829
Prelude Therapeutics
PRLD
$366M
$1K ﹤0.01%
183
-1,755
-91% -$16.1K
PROV icon
9830
Provident Financial
PROV
$111M
$1K ﹤0.01%
39
PRTC
9831
DELISTED
PureTech Health
PRTC
$1K ﹤0.01%
20
PSFM icon
9832
Pacer Swan SOS Flex April ETF
PSFM
$25.4M
$1K ﹤0.01%
+36
New +$815
QLVD icon
9833
FlexShares Developed Markets ex-US Quality Low Volatility Index Fund
QLVD
$54.8M
$1K ﹤0.01%
52
+47
+940% +$1.26K
RBOT.WS
9834
DELISTED
Vicarious Surgical Inc Warrants
RBOT.WS
$1K ﹤0.01%
600
-9,742
-94% -$9.77K
REVBW icon
9835
Revelation Biosciences Warrant
REVBW
$9.41K
$1K ﹤0.01%
6,419
-421
-6% -$108
RFFC icon
9836
ALPS Active Equity Opportunity ETF
RFFC
$30M
$1K ﹤0.01%
22
-1,279
-98% -$58.8K
RMTI icon
9837
Rockwell Medical
RMTI
$28.4M
$1K ﹤0.01%
29
-332
-92% -$14.1K
RNAC icon
9838
Cartesian Therapeutics
RNAC
$229M
$1K ﹤0.01%
39
-804
-95% -$50.3K
RULE icon
9839
Adaptive Core ETF
RULE
$15.4M
$1K ﹤0.01%
59
+55
+1,375% +$1.27K
SBFMW
9840
Sunshine Biopharma Inc Warrant
SBFMW
$94.9K
$1K ﹤0.01%
+612
New +$427
SGHC icon
9841
SGHC Ltd
SGHC
$7.11B
$1K ﹤0.01%
+101
New +$873
SGRP
9842
DELISTED
SPAR Group
SGRP
$1K ﹤0.01%
+407
New +$515
SHCO
9843
DELISTED
Soho House & Co
SHCO
$1K ﹤0.01%
125
-5,909
-98% -$52K
SHFSW icon
9844
SHF Holdings Warrants
SHFSW
$1K ﹤0.01%
+5,996
New +$2K
BNKKW
9845
DELISTED
Bonk Inc Warrant
BNKKW
$1K ﹤0.01%
+815
New +$598
SLND.WS icon
9846
Southland Holdings Warrants
SLND.WS
$1.27M
$1K ﹤0.01%
+1,700
New +$736
DCOY
9847
Decoy Therapeutics
DCOY
$2.19M
0
SMN icon
9848
ProShares UltraShort Materials
SMN
$4.17M
$1K ﹤0.01%
+25
New +$1.17K
SPXT icon
9849
ProShares S&P 500 ex-Technology ETF
SPXT
$278M
$1K ﹤0.01%
12
-193
-94% -$14.7K
SSBK
9850
DELISTED
Southern States Bancshares
SSBK
$1K ﹤0.01%
+63
New +$1.33K

Similar funds

UBS Group's Q1 2022 Portfolio in Review

As of Q1 2022, UBS Group held 11,668 positions worth $300B, down 14% from $349B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group withdrew a net $29.5B in Q1 2022, closing 1,160 positions and reducing 5,175 holdings. Its most notable exit was Xilinx Inc, an estimated $186M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

Against the trend, UBS Group opened a new position in Shell worth $66.6M.

  • UBS Group's largest Q1 2022 buy was Shell: 1,213,213 shares worth $66.6M.
  • UBS Group added most to Tesla in Q1 2022, an estimated $388M increase.
  • UBS Group's biggest Q1 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $911M.
  • UBS Group fully exited Xilinx Inc in Q1 2022, selling an estimated $186M.
  • UBS Group's ten largest holdings make up 13% of its $300B portfolio in Q1 2022.
  • UBS Group opened 1,182 new positions and closed 1,160 in Q1 2022.
  • UBS Group's portfolio value fell 14% quarter-over-quarter to $300B.

Based on UBS Group's 13F filing for Q1 2022, filed 16 May 2022.